Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Intervalo de año de publicación
1.
Braz J Anesthesiol ; 71(5): 530-537, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34097944

RESUMEN

INTRODUCTION: Asymptomatic patients with moderate functional capacity do not require Coronary Artery Disease (CAD) workup in the preoperative period of non-cardiac surgeries, especially when scheduled for minor and intermediate-risk surgeries. The workup is inappropriate because it promotes over diagnosing and pointless treatments. Moreover, those patients usually undergo cardiology assessment, in addition to pre-anesthetic evaluation. OBJECTIVE: Investigate the role of cardiology consultation as mediator in inappropriate assessment of CAD for preoperative of non-cardiac surgeries. METHOD: Retrospective study performed in a private anesthesia service using medical charts of asymptomatic patients with a history of controlled systemic disease and moderate functional capacity, submitted to pre-anesthetic consultation for minor and intermediate risk surgeries. Cardiology consultations were identified by the presence of a consultation report by a cardiologist. CAD workup was defined as undergoing cardiac stress tests. RESULTS: We included 390 medical charts of patients with mean age of 48.6 ± 15.4 years, 67% women and 69% intermediate risk surgeries. CAD workup was infrequent and performed in 3.9% of patients. Besides, pre-anesthetic evaluation, 93 (24%) patients had a cardiology consultation. Among those patients, 15.1% were submitted to CAD workup, compared to 0.34% of patients without cardiology assessment (p < 0.001; RR = 4.4; 95% CI: 3.5-5.6). CONCLUSIONS: Inappropriate testing for CAD investigation is infrequent for asymptomatic individuals submitted to minor and intermediate risk surgeries. However, cardiology consultation increases substantially the likelihood of a patient undergoing CAD workup, suggesting that, unlike the anesthesiologist, the cardiologist is a major mediator of this kind of management.


Asunto(s)
Anestésicos , Cardiología , Adulto , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Derivación y Consulta , Estudios Retrospectivos , Factores de Riesgo
2.
Am J Cardiovasc Dis ; 10(3): 219-229, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32923104

RESUMEN

BACKGROUND: Assessment of heart rate variability (HRV) is an effective non-invasive tool to obtain data on cardiac autonomic modulation and may be assessed by a range of devices, including mobile applications. Objective: This study aimed to validate a smartphone application by comparing the R-R intervals (RRi) obtained by the app with a classic electrocardiogram (ECG)-derived reference condition Methods: Fifteen asymptomatic adults (24.9±3.4 years) underwent an orthostatic challenge during which RRi were simultaneously recorded by a freeware smartphone application and by an ECG recorder. Pearson correlation coefficients (r) and coefficients of determination (r 2) were calculated to determine the degree of association between the two electronic devices. Two-way repeated measures analysis of variance and Bland-Altman analysis were used to calculate the measurement consistency and agreement, respectively, between the two methods. Effect size was also used to estimate the magnitude of the differences. RESULTS: The number of RRi from asymptomatic adults recorded by the ECG and by the free smartphone application was similar at rest in supine position (13,149 vs. 13,157; P = 0.432) and during orthostatic challenge (10,666 vs. 10,664 P = 0.532). RRi in milliseconds from both devices presented a near perfect correlation in the supine position (r = 0.999; Confidence Interval [CI] at 95%: 0.999-0.999; P < 0.0001) and during orthostatic challenge (r = 0.988; 95% CI: 0.988-0.989; P < 0.0001). A negative bias of -0.526 milliseconds (95% limits of agreement [LoA] from -4.319 to 3.266 milliseconds) was observed in supine position between ECG and the smartphone application. On the other hand, a positive bias of 0.077 milliseconds (95% LoA from -10.090 to 10.240 milliseconds) during the orthostatic challenge was observed. CONCLUSIONS: Our results cross-validated a freeware smartphone application with the ECG-derived reference condition for asymptomatic adults at rest in the supine position and during orthostatic challenge.

3.
Acta Cir Bras ; 34(8): e201900806, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31618406

RESUMEN

PURPOSE: To assess Cyclosporine A (CsA) therapy at an intraperitoneal dose of 15 mg.kg -1 in a rodent model of non-septic renal ischemia. METHODS: Twenty male Wistar rats were randomized to receive CsA therapy or none therapy before undergoing 30 minutes of renal ischemia followed by reperfusion. Additionally, 10 rats were randomized to undergo the same surgical procedure of the aforementioned animals with neither ischemia nor CsA therapy. Twelve hours after kidney ischemia, the left kidneys were evaluated for histological injury according to Park's criteria. Serum creatinine (Cr), urea nitrogen (Ur) and sodium levels were obtained at different times of the experimental protocol. RESULTS: Rodents in the CsA group showed negative results (p<0.05) in serum variables (Cr: 0.41±0.05mg/dL vs . 4.17±1.25mg/dL; Ur: 40.90±3.98mg/dL vs . 187.70±22.93mg/dL) even the non CsA or control group (Cr: 0.35±0.07mg/dL vs . 3.80±1.20mg/dL; Ur: 40.10±4.70mg/dL vs . 184.50±49.80mg/dL). The negative results were also verified in histological evaluation, CsA group had 50% in the very severe grade of lesion, 10% in the severe and 40% in the moderate to severe whereas the control group had 90% in the very severe grade. CONCLUSION: CsA was incapable of preventing the deleterious effects of ischemia-reperfusion injury in rat kidneys.


Asunto(s)
Ciclosporina/farmacología , Inmunosupresores/farmacocinética , Riñón/irrigación sanguínea , Daño por Reperfusión/tratamiento farmacológico , Animales , Creatinina/sangre , Modelos Animales de Enfermedad , Isquemia/prevención & control , Riñón/efectos de los fármacos , Masculino , Ratas , Ratas Wistar , Daño por Reperfusión/patología , Sodio/sangre , Urea/sangre
4.
Acta cir. bras ; 34(8): e201900806, 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1038123

RESUMEN

Abstract Purpose To assess Cyclosporine A (CsA) therapy at an intraperitoneal dose of 15 mg.kg -1 in a rodent model of non-septic renal ischemia. Methods Twenty male Wistar rats were randomized to receive CsA therapy or none therapy before undergoing 30 minutes of renal ischemia followed by reperfusion. Additionally, 10 rats were randomized to undergo the same surgical procedure of the aforementioned animals with neither ischemia nor CsA therapy. Twelve hours after kidney ischemia, the left kidneys were evaluated for histological injury according to Park's criteria. Serum creatinine (Cr), urea nitrogen (Ur) and sodium levels were obtained at different times of the experimental protocol. Results Rodents in the CsA group showed negative results (p<0.05) in serum variables (Cr: 0.41±0.05mg/dL vs . 4.17±1.25mg/dL; Ur: 40.90±3.98mg/dL vs . 187.70±22.93mg/dL) even the non CsA or control group (Cr: 0.35±0.07mg/dL vs . 3.80±1.20mg/dL; Ur: 40.10±4.70mg/dL vs . 184.50±49.80mg/dL). The negative results were also verified in histological evaluation, CsA group had 50% in the very severe grade of lesion, 10% in the severe and 40% in the moderate to severe whereas the control group had 90% in the very severe grade. Conclusion CsA was incapable of preventing the deleterious effects of ischemia-reperfusion injury in rat kidneys.


Asunto(s)
Animales , Masculino , Ratas , Daño por Reperfusión/tratamiento farmacológico , Ciclosporina/farmacología , Inmunosupresores/farmacocinética , Riñón/irrigación sanguínea , Sodio/sangre , Urea/sangre , Daño por Reperfusión/patología , Ratas Wistar , Creatinina/sangre , Modelos Animales de Enfermedad , Isquemia/prevención & control , Riñón/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...